
January 2026
RCEM Learning
00:00
Trial design and population
Andy describes inclusion (pH<7.2 with AKI), exclusions, unblinded 4.2% bicarbonate infusion, and primary 90-day mortality outcome.
Play episode from 40:26
Transcript

Andy describes inclusion (pH<7.2 with AKI), exclusions, unblinded 4.2% bicarbonate infusion, and primary 90-day mortality outcome.